The global apheresis market size was US$ 2,415.3 million in 2021. The global apheresis market size is forecast to reach US$ 4775.4 million by 2030, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period from 2022 to 2030.

Apheresis is a medical technology that passes a person's blood through an apparatus that separates one particular constituent and returns the remainder to the circulation. Thus, it is an extracorporeal therapy. The primary use of apheresis is for collecting stem cells. The process of apheresis varies according to the substance removed. Centrifugation is the most common method for separation by density. In other methods, beads are coated with an absorbent material and filtered.

Factors Influencing Market Growth

• Among the factors driving the global apheresis market include rising demand for blood components worldwide and increasing government initiatives toward blood donation.
• The global market is growing due to the recently approved signs for apheresis treatment, including acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and cardiac neonatal lupus.
• The absence of skilled professionals and complications associated with the apheresis procedure may slow down the overall market growth.
• The growing demand for plasma-derived pharmaceuticals presents lucrative growth opportunities for the global market during the forecast period.

Impact Analysis of COVID-19

The COVID-19 pandemic had a positive impact on the global apheresis market due to the vast application of plasma therapy in the remedy of COVID-19 infected patients. Furthermore, the US FDA granted emergency use authorization (EUA) for convalescent plasma (CCP) therapy in hospitalized COVID-19 patients in August 2020. Terumo BCT Inc. and Marker Therapeutics AG also gained FDA clearance in April 2020 for the Emergency Use Authorization (EUA) of Terumo BCT's Spectra Optia Apheresis System in combination with Marker Therapeutics' D2000 Adsorption Cartridge to treat COVID-19 disease in patients aged 18 and up.

Regional Insights

The Asia Pacific region is forecast to have a lucrative growth rate in the market during the forecast period. As a result of the growing population base, increasing disposable income, and rising patient awareness of blood donation. In addition, a surge in the incidence of dengue across countries in the Asia Pacific region is a factor driving the market growth in the region.

Leading Competitors

The leading prominent companies profiled in the global apheresis market are:

• Haemonetics Corporation
• Fresenius Kabi
• Terumo BCT, Inc
• Asahi Kasei Medical Co., Ltd
• HemaCare Corporation
• Kaneka Corporation
• Kawasumi Laboratories Inc
• Cerus Corporation
• B. Braun Melsungen AG
• Nikkiso Co., Ltd
• Other Prominent Players

Scope of the Report

The global apheresis market segmentation focuses on Product, Apheresis Procedure, Technology, Application, and Region.

Segmentation based on Product

• Devices
• Disposable

Segmentation based on Apheresis Procedure

• Leukapheresis
• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Other Apheresis Procedures

Segmentation based on Technology

• Centrifugation
• Membrane Separation

Segmentation based on Application

• Renal Disorders
• Hematological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Other Applications

Segmentation based on Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America